A neurodegenerative perspective on mitochondrial optic neuropathies
Open accessThe DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Mitochondrial optic neuropathies constitute an important cause of chronic visual morbidity and registrable blindness in both the paediatric and adult population. It is a genetically heterogeneous group of disorders caused by both mitochondrial DNA (mtDNA) mutations and a growing list of nuclear genetic defects that invariably affect a critical component of the mitochondrial machinery. The two classical paradigms are Leber hereditary optic neuropathy (LHON), which is a primary mtDNA disorder, and autosomal dominant optic atrophy (DOA) secondary to pathogenic mutations within the nuclear gene OPA1 that encodes for a mitochondrial inner membrane protein. The defining neuropathological feature is the preferential loss of retinal ganglion cells (RGCs) within the inner retina but, rather strikingly, the smaller calibre RGCs that constitute the papillomacular bundle are particularly vulnerable, whereas melanopsin-containing RGCs are relatively spared. Although the majority of patients with LHON and DOA will present with isolated optic nerve involvement, some individuals will also develop additional neurological complications pointing towards a greater vulnerability of the central nervous system (CNS) in susceptible mutation carriers. These so-called "plus" phenotypes are mechanistically important as they put the loss of RGCs within the broader perspective of neuronal loss and mitochondrial dysfunction, highlighting common pathways that could be modulated to halt progressive neurodegeneration in other related CNS disorders. The management of patients with mitochondrial optic neuropathies still remains largely supportive, but the development of effective disease-modifying treatments is now within tantalising reach helped by major advances in drug discovery and delivery, and targeted genetic manipulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 LHON-MS overlap syndrome. T2 MRI images from a 27-year-old woman with episodes of recurrent optic neuritis over a 10-year period associated with partial visual recovery. There are disseminated high-signal changes within the white matter regions of the brain and cervical spinal cord that are consistent with demyelination [105]](https://figures.cochat.ai/paper-figures/21040ea5b7d6449ab0f37b733fbc8126/a-neurodegenerative-perspective-on-mitochondrial-optic-neuropathies-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The m.11778G>A mutation is the most common LHON mutation, accounting for about 70% of LHON in North America and Europe.1,3,4”
From Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy (2023) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Approximately 90% of all LHON cases are caused by one of three point mutations in the mtDNA: m.3460G>A in MT-ND1, m.11778G>A in MT-ND4 and m.14484T>C in MT-ND6.4”
From Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy (2023) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K. (1988) · Science · doi:10.1126/science.3201231 · Cited by 2,440 · cited 1×
“11778G>A LHON mutation was the first mtDNA variant linked with human disease and despite three decades of intensive research, there are still several unsolved mysteries, in particular the marked incomplete penetrance and the sex bias associated with this mitochondrial disorder [134].”
BackgroundThe spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179 · cited 13×
“The overlap between LHON and a multiple sclerosis (MS)-like illness (Harding disease) is a fascinating association that highlights a potential final common pathway linking mitochondrial dysfunction with neuronal loss and disease progression in acquired demyelinating disorders affecting the central nervous system (CNS).”
BackgroundInfluentialMutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572
Delettre, C., Lenaers, G., Griffoin, J.-M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000) · Nature Genetics · doi:10.1038/79936 · Cited by 1,446 · cited 1×
“1 3 encodes for a mitochondrial inner membrane protein with multifunctional properties [4, 47].”
BackgroundAlexander, C., Votruba, M., Pesch, U. E. A., Thiselton, D. L., Mayer, S., Moore, A., Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., et al. (2000) · Nature Genetics · doi:10.1038/79944 · Cited by 1,330
Self-citationPrevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
Gorman, G. S., Schaefer, A. M., Ng, Y., Gomez, N., Blakely, E. L., Alston, C. L., Feeney, C., Horvath, R., Yu‐Wai‐Man, P., Chinnery, P. F., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24362 · Cited by 936 · cited 1×
“Mitochondrial diseases affect at least 1 in 4300 of the population and patients can present with either isolated or multisystemic organ involvement [58].”
BackgroundSelf-citationMitochondrial dysfunction as a cause of optic neuropathies
Carelli, V., Ross-Cisneros, F. N., & Sadun, A. A. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.10.003 · Cited by 839 · cited 4×
“14459G>A) in isolated families from Holland, Australia and North America have previously been linked with particularly severe LHON “plus” phenotypes complicated by spastic dystonia, ataxia, juvenile-onset encephalopathy, and psychiatric disturbances [35, 143].”
BackgroundInfluentialSelf-citationA Lethal Defect of Mitochondrial and Peroxisomal Fission
Waterham, H. R., Koster, J., van Roermund, C. W. T., Mooyer, P. A. W., Wanders, R. J. A., & Leonard, J. V. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064436 · Cited by 749 · cited 1×
“Interestingly, DRP1 is also a pro-fission cytosolic protein that is recruited to the mitochondrial outer membrane, and both SPG7 and AFG3L2 encode for mitochondrial AAA proteases that operate as oligomeric complexes to regulate the post-translational processing of OPA1 [39, 78, 135].”
BackgroundRoemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716 · cited 1×
“After decades of debate, clinicopathological studies have revealed striking differences between NMO and prototypic MS firmly establishing the two of them as distinct disease entities [23, 95, 113].”
ResultDisturbed mitochondrial dynamics and neurodegenerative disorders
Burté, F., Carelli, V., Chinnery, P. F., & Yu-Wai-Man, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.228 · Cited by 660 · cited 16×
“Rather strikingly, with the exception of WFS1, which encodes for an endoplasmic reticulum protein, all proteins associated with DOA are closely involved in regulating mitochondrial dynamics, pointing towards a key biological pathway essential for RGC maintenance and survival (Table 1) [28, 110].”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 1
- Sadun AAKY, Wurdeman AE, Dao J, Heller K, Sherman J (1994) Morphological findings in the visual system in a case of Leber’s hereditary optic neuropathy. Clin Neurosci 2:165–172
Cited by
Yu-Wai-Man, P., Newman, N. J., Carelli, V., Moster, M. L., Biousse, V., Sadun, A. A., Klopstock, T., Vignal-Clermont, C., Sergott, R. C., Rudolph, G., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz7423 · Cited by 232
“11778G>A being the most common mutation worldwide (1, 3, 4).”
BackgroundSelf-citationCarelli, V., Carbonelli, M., de Coo, I. F., Kawasaki, A., Klopstock, T., Lagrèze, W. A., La Morgia, C., Newman, N. J., Orssaud, C., Pott, J. W. R., et al. (2017) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000570 · Cited by 228
“Thinning of the macular RGC layer measured by OCT is largely completed in 4–6 months, highlighting the severe cell loss of the cells originating the papillomacular bundle (8,49).”
BackgroundSelf-citationMitochondrial disease in children
Rahman, S. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13054 · Cited by 178
Newman, N. J., Yu-Wai-Man, P., Carelli, V., Moster, M. L., Biousse, V., Vignal-Clermont, C., Sergott, R. C., Klopstock, T., Sadun, A. A., Barboni, P., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.12.012 · Cited by 168
“11778G>A being the most common mutation worldwide.(1,3) These mutations affect complex I subunits of the mitochondrial respiratory chain, impairing mitochondrial function and increasing the levels of reactive oxygen species.”
BackgroundSelf-citationImpaired complex I repair causes recessive Leber’s hereditary optic neuropathy
Stenton, S. L., Sheremet, N. L., Catarino, C. B., Andreeva, N. A., Assouline, Z., Barboni, P., Barel, O., Berutti, R., Bychkov, I. O., Caporali, L., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci138267 · Cited by 163
“The disease arises during young adult life and displays a gender dependent incomplete penetrance of 50% in males and 10% in females (3), resulting in five times more males being affected.”
BackgroundSelf-citationGenetic Counselling for Maternally Inherited Mitochondrial Disorders
Poulton, J., Finsterer, J., & Yu‐Wai‐Man, P. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0279-7 · Cited by 140
“14484T[C mutation carries the best visual prognosis, but it is not possible to predict which patients will experience spontaneous visual recovery, nor the timing or the extent [64].”
Self-citationRetinal Ganglion Cells and Circadian Rhythms in Alzheimer’s Disease, Parkinson’s Disease, and Beyond
Morgia, C. L., Ross‐Cisneros, F. N., Sadun, A. A., & Carelli, V. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00162 · Cited by 126
Self-citationOptic neuropathies: the tip of the neurodegeneration iceberg
Carelli, V., Morgia, C. L., Ross‐Cisneros, F. N., & Sadun, A. A. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx273 · Cited by 122
Self-citationDominant optic atrophy: Culprit mitochondria in the optic nerve
Lenaers, G., Neutzner, A., Dantec, Y. L., Jüschke, C., Xiao, T., Decembrini, S., Swirski, S., Kieninger, S., Ağca, C., Kim, U. S., et al. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100935 · Cited by 117
Self-citationNewman, N. J., Carelli, V., Taiel, M., & Yu-Wai-Man, P. (2020) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001045 · Cited by 111
Self-citationSSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder
Dotto, V. D., Ullah, F., Meo, I. D., Magini, P., Gušić, M., Maresca, A., Caporali, L., Palombo, F., Tagliavini, F., Baugh, E. H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128514 · Cited by 101
“The expanding genetic landscape of inherited optic neuropathies has highlighted mitochondrial 20 dysfunction as a major driver of this pathology (1, 2).”
BackgroundSelf-citationNewman, N. J., Yu-Wai-Man, P., Biousse, V., & Carelli, V. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00174-0 · Cited by 97
Self-citationTherapeutic Options in Hereditary Optic Neuropathies
Amore, G., Romagnoli, M., Carbonelli, M., Barboni, P., Carelli, V., & Morgia, C. L. (2020) · Drugs · doi:10.1007/s40265-020-01428-3 · Cited by 97
“Understanding the underlying pathogenic mechanisms and natural history of HONs, together with the knowledge of naturally occurring cellular compensatory strategies, are all crucial steps for identifying specific pathways to target in the development of new therapeutic strategies, currently limited mainly to LHON [8, 9…”
BackgroundSelf-citationRandomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy
Newman, N. J., Yu-Wai-Man, P., Subramanian, P. S., Moster, M. L., Wang, A.-G., Donahue, S. P., Leroy, B. P., Carelli, V., Biousse, V., Vignal-Clermont, C., et al. (2023) · Brain · doi:10.1093/brain/awac421 · Cited by 87
“4 A primary mtDNA mutation is necessary, but not sufficient to cause vision loss, as there is well-documented incomplete penetrance with 20– 50% of male and 4–20% of female carriers manifesting the clinical disease during their lifetime.5 The m.11778G>A mutation is the most common LHON mutation, accounting for about 7…”
InfluentialSelf-citationOPA1: How much do we know to approach therapy?
Dotto, V. D., Fogazza, M., Lenaers, G., Rugolo, M., Carelli, V., & Zanna, C. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.018 · Cited by 79
Self-citationNatural history of patients with Leber hereditary optic neuropathy—results from the REALITY study
Yu‐Wai‐Man, P., Newman, N. J., Carelli, V., Morgia, C. L., Biousse, V., Bandello, F. M., Vignal‐Clermont, C., Castillo, L., Leruez, S., Moster, M. L., et al. (2021) · Eye · doi:10.1038/s41433-021-01535-9 · Cited by 78
“Retinal ganglion cells (RGCs) are particularly vulnerable to mitochondrial dysfunction, which may lead to apoptotic cell death and axonal degeneration, ultimately resulting in optic atrophy [5, 6].”
BackgroundSelf-citationLeber hereditary optic neuropathy: bridging the translational gap
Jurkutė, N., & Yu‐Wai‐Man, P. (2017) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000410 · Cited by 75
Self-citationMuraresku, C. C., McCormick, E. M., & Falk, M. J. (2018) · Current Genetic Medicine Reports · doi:10.1007/s40142-018-0138-9 · Cited by 72
Inherited eye-related disorders due to mitochondrial dysfunction
Yu‐Wai‐Man, P., & Newman, N. J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx182 · Cited by 66
Self-citationNewman, N. J., Yu-Wai-Man, P., Carelli, V., Biousse, V., Moster, M. L., Vignal-Clermont, C., Sergott, R. C., Klopstock, T., Sadun, A. A., Girmens, J.-F., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.662838 · Cited by 64
Self-citationDopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
Indrieri, A., Pizzarelli, R., Franco, B., & Leonibus, E. D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.567129 · Cited by 63
Loss of the mitochondrial i‐AAA protease YME1L leads to ocular dysfunction and spinal axonopathy
Sprenger, H., Wani, G. A., Hesseling, A., König, T., Patrón, M., MacVicar, T., Ahola, S., Wai, T., Barth, E., Rugarli, E. I., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809288 · Cited by 62
“The degenerative phenotype of NYKO mice is distinct from mouse models of OXPHOS dysfunction, which show optic neuropathy characterized by the loss of retinal ganglion cells combined with brain atrophy (Fukui et al, 2007; Kruse et al, 2008; Quintana et al, 2010; Yu-Wai-Man et al, 2016).”
BackgroundATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy
Caporali, L., Magri, S., Legati, A., Dotto, V. D., Tagliavini, F., Balistreri, F., Nasca, A., Morgia, C. L., Carbonelli, M., Valentino, M. L., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25723 · Cited by 58
“This latter study demonstrates that optic neuropathy may result from impairment of either fusion or fission, both leading to opposite profound dysfunction of mitochondrial dynamics.(45) The impairment of the finely tuned mitodynamic processes affects mitochondrial morphology, bioenergetic efficiency, and ultimately mi…”
BackgroundSelf-citationMitochondrial optic neuropathies
Carelli, V., Morgia, C. L., & Yu‐Wai‐Man, P. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-12-821751-1.00010-5 · Cited by 55
Self-citationAutophagy controls the pathogenicity of OPA 1 mutations in dominant optic atrophy
Kane, M. S., Alban, J., Desquiret‐Dumas, V., Guéguen, N., Ishak, L., Ferré, M., Amati‐Bonneau, P., Procaccio, V., Bonneau, D., Lenaers, G., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13149 · Cited by 54
“These findings are in agreement with previous reports categorizing these missense mutations as dominant-negative OPA1 mutations [14].”
BackgroundResultInfluentialIs the Eye an Extension of the Brain in Central Nervous System Disease?
Groef, L. D., & Cordeiro, M. F. (2017) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2016.0180 · Cited by 53
Leber hereditary optic neuropathy—new insights and old challenges
Sundaramurthy, S., Selvakumar, A., Ching, J., Dharani, V., Sarangapani, S., & Yu‐Wai‐Man, P. (2020) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-020-04993-1 · Cited by 53
Self-citationVignal-Clermont, C., Girmens, J.-F., Audo, I., Said, S. M., Errera, M.-H., Plaine, L., O’Shaughnessy, D., Taiel, M., & Sahel, J.-A. (2021) · BioDrugs · doi:10.1007/s40259-021-00468-9 · Cited by 51
“The 11778-ND4 mutation is the most frequent, accounting for about 75% of LHON in North America and Europe [1, 4, 7].”
BackgroundInfluentialDNAJC30 defect: a frequent cause of recessive Leber hereditary optic neuropathy and Leigh syndrome
Stenton, S. L., Tesařová, M., Sheremet, N. L., Catarino, C. B., Carelli, V., Ciara, E., Curry, K., Engvall, M., Fleming, L. R., Freisinger, P., et al. (2022) · Brain · doi:10.1093/brain/awac052 · Cited by 50
Self-citationMeta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy
Ham, M., Han, J., Osann, K., Smith, M., & Kimonis, V. E. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.07.006 · Cited by 48
Shiga, Y., Nishida, T., Jeoung, J. W., Polo, A. D., & Fortune, B. A. (2023) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1217125 · Cited by 47
Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges
Falabella, M., Minczuk, M. A., Hanna, M. G., Viscomi, C. F., & Pitceathly, R. D. S. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00715-9 · Cited by 47
Novel mutations in the mitochondrial complex I assembly gene NDUFAF5 reveal heterogeneous phenotypes
Simon, M. T., Eftekharian, S. S., Stover, A. E., Osborne, A. F., Braffman, B. H., Chang, R. C., Wang, R., Steenari, M., Tang, S., Hwu, W., et al. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.11.001 · Cited by 46
The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis
Mendoza‐Santiesteban, C. E., Gabilondo, I., Palma, J., Norcliffe‐Kaufmann, L., & Kaufmann, H. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00206 · Cited by 45
“Pathological studies showed retinal damage in patients with Alzheimer disease (16), multiple sclerosis (17), idiopathic PD (18, 19), MSA (6), and mitochondrial neurodegenerative disorders (20).”
BackgroundKurzawa‐Akanbi, M., Tzoumas, N., Corral-Serrano, J. C., Guarascio, R., STEEL, D. H., Cheetham, M. E., Armstrong, L., & Lako, M. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101248 · Cited by 44
Jurkutė, N., Majander, A. S., Bowman, R. J. C., Votruba, M., Abbs, S. J., Acheson, J. F., Lenaers, G., Amati‐Bonneau, P., Moosajee, M., Arno, G., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0235-y · Cited by 42
“Optic atrophy has also been reported as a variable clinical feature in patients with other classical mitochondrial syndromes, for example, maternally inherited Leigh syndrome (MILS); myoclonic epilepsy associated with ragged-red fibres (MERRF); the syndrome of neuropathy, ataxia, and retinitis pigmentosa (NARP); mitoc…”
BackgroundSelf-citationFive-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy
Yu‐Wai‐Man, P., Newman, N. J., Biousse, V., Carelli, V., Moster, M. L., Vignal‐Clermont, C., Klopstock, T., Sadun, A. A., Sergott, R. C., Hage, R., et al. (2024) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2024.5375 · Cited by 41
Self-citationSun, S., Erchova, I. A., Sengpiel, F., & Votruba, M. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.6.42 · Cited by 36
Self-citationMitochondrial DNA: Consensuses and Controversies
Shokolenko, I. N., & ALEXEYEV, M. F. (2022) · DNA · doi:10.3390/dna2020010 · Cited by 36
“Over the years, mtDNA alterations have been implicated in the pathogenesis of virtually all organ systems: respiratory system [7,8], digestive and excretory system [9,10], circulatory system [11,12], urinary system [13], integumentary system [14,15], skeletal system [16,17], muscular system [18], endocrine system [18]…”
BackgroundInsights into the genotype-phenotype correlation and molecular function of SLC25A46
Abrams, A. J., Fontanesi, F., Tan, N. B., Buglo, E., Campeanu, I. J., Rebelo, A. P., Kornberg, A. J., Phelan, D., Stark, Z., & Zuchner, S. L. (2018) · Human Mutation · doi:10.1002/humu.23639 · Cited by 35
“Specific presentations range from optic atrophy—plus disorder on the mild end of the spectrum to lethal Leigh syndrome and ponto-cerebellar hypoplasia in extreme cases (Janer et al., 2016;Wan et al., 2016; Yu-Wai-Man et al., 2016).”
BackgroundPathophysiological Heterogeneity of the BBSOA Neurodevelopmental Syndrome
Bertacchi, M., Tocco, C., Schaaf, C. P., & Studer, M. (2022) · Cells · doi:10.3390/cells11081260 · Cited by 35
“As an example, in autosomal dominant or recessive OA caused by pathogenic OPA1 (OMIM 605290) and WFS1 (OMIM 606201) variants, progressive RGC loss starts in early childhood, and most patients are registered as legally blind by the fifth decade of life [58].”
BackgroundIdebenone does not inhibit disability progression in primary progressive MS
Kosa, P. F., Wu, T., Phillips, J., Leinonen, M., Masvekar, R., Komori, M., Wichman, A., Sandford, M., & Bielekova, B. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102434 · Cited by 34
Kieninger, S., Xiao, T., Weisschuh, N., Kohl, S., Rüther, K., Kroisel, P. M., Brockmann, T., Knappe, S., Kellner, U., Lagrèze, W. A., et al. (2022) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2021-108235 · Cited by 32
Carelli, V., Newman, N. J., Yu‐Wai‐Man, P., Biousse, V., Moster, M. L., Subramanian, P. S., Vignal‐Clermont, C., Wang, A.-G., Donahue, S. P., Leroy, B. P., et al. (2022) · Ophthalmology and Therapy · doi:10.1007/s40123-022-00611-x · Cited by 30
“Most of the LHON causative mutations affect mitochondrial DNA (mtDNA) genes encoding for NADH dehydrogenase (ND) subunits of the respiratory chain complex I, leading to a subacute and catastrophic degeneration of retinal ganglion cells (RGCs) (with the final outcome of optic nerve atrophy) [1].”
BackgroundSelf-citationShi, C., Jiang, H., Gameiro, G. R., Hu, H., Hernandez, J., Delgado, S. R., & Wang, J. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-25809 · Cited by 30
“is considered to contribute to MS pathophysiology, and the location of the M zone is similar to the findings of mitochondrial optic neuropathies.(31,38) In longitudinal studies of Leber’s hereditary optic neuropathy, the nasal focal thinning of GCIPL occurred at the presymptomatic stage before the diffuse thinning of…”
ResultGene Therapies for the Treatment of Leber Hereditary Optic Neuropathy
Sahel, J., Newman, N. J., Yu‐Wai‐Man, P., Vignal‐Clermont, C., Carelli, V., Biousse, V., Moster, M. L., Sergott, R. C., Klopstock, T., Sadun, A. A., et al. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000364 · Cited by 30
Self-citationBocca, C., Nzoughet, J. K., Leruez, S., Amati‐Bonneau, P., Ferré, M., Kane, M.-S., Veyrat‐Durebex, C., de la Barca, J. M. C., Chevrollier, A., Homedan, C., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23027 · Cited by 28
SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy
Bitetto, G., Malaguti, M. C., Ceravolo, R., Monfrini, E., Straniero, L., Morini, A., Giacopo, R. D., Frosini, D., Palermo, G., Biella, F., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.03.018 · Cited by 28
Jurkutė, N., Bertacchi, M., Arno, G., Tocco, C., Kim, U. S., Kruszewski, A. M., Avery, R. A., Bedoukian, E. C., Han, J., Ahn, S. J., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab162 · Cited by 28
“childhood and most patients are registered legally blind by the fifth decade of life.(3) High-resolution optical coherence tomography (OCT) imaging has made it possible to”
BackgroundSelf-citationAleo, S. J., Dotto, V. D., Romagnoli, M., Fiorini, C., Capirossi, G., Peron, C., Maresca, A., Caporali, L., Capristo, M., Tropeano, C. V., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101383 · Cited by 28
“13 Recently, other rare recessive genetic defects were also associated with LHON but affecting CI.”
BackgroundSelf-citationChichagova, V., Hallam, D., Collin, J., Buskin, A., Saretzki, G. C., Armstrong, L., Yu‐Wai‐Man, P., Lako, M., & STEEL, D. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12396-2 · Cited by 28
Self-citationLow disease risk and penetrance in Leber hereditary optic neuropathy
Watson, E. C., Davis, R. L., Ravishankar, S., Copty, J., Kummerfeld, S., & Sue, C. M. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.11.013 · Cited by 26
Khan, N. A., Govindaraj, P., Soumittra, N., Sharma, S., Srilekha, S., Selvakumar, A., Vanniarajan, A., Meena, A. K., Uppin, M. S., Challa, S., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20695 · Cited by 26
VIGNAL-CLERMONT, C., YU-WAI-MAN, P., NEWMAN, N. J., CARELLI, V., MOSTER, M. L., BIOUSSE, V., SUBRAMANIAN, P. S., WANG, A.-G., DONAHUE, S. P., LEROY, B. P., et al. (2023) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.11.026 · Cited by 25
Self-citationMitochondrial neuropathy and neurogenic features in mitochondrial myopathy
Lu, J., & Tarnopolsky, M. A. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.005 · Cited by 25
Bevan, R. J., Williams, P. A., Waters, C. T., Thirgood, R. A., Mui, A., Seto, S., Good, M. A., Morgan, J. E., Votruba, M., & Erchova, I. A. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa101 · Cited by 24
Self-citationCharif, M., Bris, C., Goudenège, D., Desquiret‐Dumas, V., Colin, E., Ziegler, A. C., Procaccio, V., Reynier, P., Bonneau, D., Lenaers, G., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.602979 · Cited by 24
“Conversely, the frequency of autosomal recessive optic neuropathies, which was initially described as very low, is now progressing, thanks to NGS, with an increasing number of genes involved (30).”
BackgroundΜitochondrial Membrane Dynamics and Inherited Optic Neuropathies
Bagli, E., Zikou, A. K., Agnantis, N. J., & Kitsos, G. (2017) · In Vivo · doi:10.21873/invivo.11090 · Cited by 24
Sladen, P. E., Jovanovic, K., Guarascio, R., Ottaviani, D., Salsbury, G., Novoselova, T. V., Chapple, J. P., Yu‐Wai‐Man, P., & Cheetham, M. E. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac128 · Cited by 23
Self-citationElectrodiagnostic tests of the visual pathway and applications in neuro-ophthalmology
Calcagni, A., Neveu, M. M., Jurkutė, N., & Robson, A. G. (2024) · Eye · doi:10.1038/s41433-024-03154-6 · Cited by 23
“The characteristics of RGCs make them particularly vulnerable to mitochondrial dysfunction, due to their long axons which rely heavily on energy from mitochondria [35, 36].”
BackgroundPihl-Jensen, G., Wanscher, B., & Frederiksen, J. L. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520917924 · Cited by 23
Lee, J., Choi, S.-H., Kim, Y., Jun, I., Sung, J. J., Lee, D. R., Kim, Y. I., Cho, M. S., Byeon, S. H., Kim, D., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23439 · Cited by 23
“The loss of RGCs has been also implicated in genetic optic neuropathy, such as Leber’s hereditary optic neuropathy and dominant optic atrophy.(6) Both optic neuropathies show bilateral and aggressive loss of vision in younger patients, and no promising treatment has been developed for these conditions.”
BackgroundNewman, N. J., Biousse, V., Yu‐Wai‐Man, P., Carelli, V., Vignal‐Clermont, C., Montestruc, F., Taiel, M., & Sahel, J. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.10.002 · Cited by 22
Self-citationYu, A. K., Datta, S., McMackin, M. Z., & Cortopassi, G. A. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx373 · Cited by 22
Hu, H., Jiang, H., Gameiro, G. R., Hernandez, J., Delgado, S. R., & Wang, J. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27574 · Cited by 22
Molecular Mechanisms behind Inherited Neurodegeneration of the Optic Nerve
Maresca, A., & Carelli, V. (2021) · Biomolecules · doi:10.3390/biom11040496 · Cited by 22
“As DOA and LHON are largely mono-symptomatic disorders, it must be remarked that an incredibly wide spectrum of other mitochondrial disorders including optic atrophy as defining feature, starting from the DOA “plus” [2,11] and LHON “plus” [2–4] variants, are described and continue to be described.”
BackgroundSelf-citationCullen, P., & Sun, D. (2023) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1217137 · Cited by 21
“…vulnerable to the metabolic consequences of mitochondrial dysfunction, making it the primary site of neurological damage in mitochondrial disorders such as Leber’s hereditary optic neuropathy and dominant optic atrophy, known collectively as Mitochondrial Optic Neuropathies (MON) (83, 84, 141).”
BackgroundHarvey, J. P., Sladen, P. E., Yu‐Wai‐Man, P., & Cheetham, M. E. (2021) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001375 · Cited by 21
Self-citationIncreasing mtDNA levels as therapy for mitochondrial optic neuropathies
Ruiz‐Pesini, E., Emperador, S., López‐Gallardo, E., Hernández‐Ainsa, C., & Montoya, J. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.031 · Cited by 21
Li, J., Li, W., Gao, F., Qu, S., Hu, F., Zhang, S.-H., Li, L., Wang, Z., Qiu, Y., Wang, L.-S., et al. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.8.11 · Cited by 20
Liu, Y., Eastwood, J. D., Alba, D. E., Velmurugan, S., Sun, N., Porciatti, V., Lee, R. K., Hauswirth, W. W., Guy, J., & Yu, H. (2022) · Gene Therapy · doi:10.1038/s41434-022-00333-6 · Cited by 19
“One of the most common hypotheses about the disease is that mtDNA mutations disrupt essential polypeptide subunits of complex I and lead to ATP production impairment, resulting in apoptosis of the retinal ganglion cells (RGCs) 8, 47–53 .”
Cranial Pair II: The Optic Nerves
Herrera, E., Agudo‐Barriuso, M., & Murcia‐Belmonte, V. (2018) · The Anatomical Record · doi:10.1002/ar.23922 · Cited by 19
“…injury (Barron et al., 1986; Humphrey and Moore, 1996; Panagis et al., 2005; Raibon et al., 2002; Schnitzer and Scherer, 1990; Thanos et al., 1994; Zhang et al., 2005) to clear RGC debris when these cells degenerate after ON injury (Baptiste et al., 2005; Barron et al., 1986; Galindo-Romero et…”
BackgroundAxon regeneration after optic nerve injury in rats can be improved via PirB knockdown in the retina
Yang, M., Jian, L., Fan, W., Chen, X., Zou, H., Huang, Y., Chen, X.-F., Zhou, Y., & Yuan, R. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00670-w · Cited by 19
“Trauma, glaucoma, hypoxia and other factors can cause optic nerve injury (ONI) [1, 2].”
BackgroundNeuroimaging in Leber Hereditary Optic Neuropathy: State-of-the-art and future prospects
Chow-Wing-Bom, H. T., Callaghan, M. F., Wang, J., Wei, S., Dick, F., Yu‐Wai‐Man, P., & Dekker, T. M. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103240 · Cited by 18
“Patients with this variant of the disease, described as LHON Plus, also present with demyelinating lesions in their central nervous system, which has led to associations between LHON and multiple sclerosis (Matthews et al., 2015; Yu-Wai-Man et al., 2016; Carelli et al., 2019).”
BackgroundSelf-citationClinical and genetic landscape of optic atrophy in 826 families: insights from 50 nuclear genes
Zheng, Y., Wang, P., Li, S., Long, Y., Jiang, Y., Guo, D., Jia, X., Liu, M., Zeng, Y., Xiao, X., et al. (2024) · Brain · doi:10.1093/brain/awae324 · Cited by 18
Bocca, C., Kane, M. S., Veyrat‐Durebex, C., Nzoughet, J. K., de la Barca, J. M. C., Chupin, S., Alban, J., Procaccio, V., Bonneau, D., Simard, G., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00081 · Cited by 18
An evaluation of genetic causes and environmental risks for bilateral optic atrophy
Chen, A. T., Brady, L., Bulman, D. E., Sundaram, A. N. E., Rodriguez, A. R., Margolin, E., Waye, J. S., & Tarnopolsky, M. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225656 · Cited by 18
“All three variants affect complex I subunits of the respiratory chain, resulting in impaired oxidative phosphorylation and increased levels of reactive oxygen species (ROS) [7,8].”
BackgroundKaranjia, R., Yu‐Wai‐Man, P., & Newman, N. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_45 · Cited by 18
Self-citationCharif, M., Wong, Y. C., Kim, S., Guichet, A., Vignal‐Clermont, C., Zanlonghi, X., Bensaïd, P., Procaccio, V., Bonneau, D., Amati‐Bonneau, P., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00431-w · Cited by 16
“Main text Inherited Optic Neuropathies (ION) are the most common mitochondrial diseases, leading to the irreversible loss of retinal ganglion cells, optic nerve degeneration and central visual loss [1, 2].”
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations
Aleo, S. J., Dotto, V. D., Fogazza, M., Maresca, A., Lodi, T., Goffrini, P., Ghelli, A. M., Rugolo, M., Carelli, V., Baruffini, E., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa244 · Cited by 15
“has deleterious effect on ATP production and elevated ROS level (67).”
BackgroundSelf-citationde la Barca, J. M. C., Arrázola, M. S., Bocca, C., Pelloquin, L., Iuliano, O., Tcherkez, G. G. B., Lenaers, G., Simard, G., Belenguer, P., & Reynier, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-42554-7 · Cited by 15
Zanfardino, P., Amati, A., Doccini, S., Cox, S. N., Tullo, A., Longo, G., D’Erchia, A. M., Picardi, E., Nesti, C., Santorelli, F. M., et al. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae008 · Cited by 14
Shi, Y., Ye, D., Cui, K., Bai, X., Fan, M., Feng, Y., Hu, C., Xu, Y., & Huang, J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167053 · Cited by 14
Cullen, P., Gammerdinger, W., Sui, S. J. H., Mazumder, A. G., & Sun, D. (2024) · Glia · doi:10.1002/glia.24571 · Cited by 14
From Bench to Bedside—Delivering Gene Therapy for Leber Hereditary Optic Neuropathy
Chen, B. S., & Yu‐Wai‐Man, P. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041282 · Cited by 14
Self-citationCombined Optic Atrophy and Rod–Cone Dystrophy Expands the RTN4IP1 (Optic Atrophy 10) Phenotype
Rajabian, F., Manitto, M. P., Palombo, F., Caporali, L., Moretti, A. G., Starace, V., Arrigo, A., Cascavilla, M. L., Morgia, C. L., Barboni, P., et al. (2020) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001124 · Cited by 14
“This fits with the phenotypic expression of optic atrophy as Leber hereditary optic neuropathy and dominant optic atrophy (4).”
BackgroundSelf-citationKurimoto, T., Ueda, K., Mori, S., Kamada, S., Sakamoto, M., Yamada‐Nakanishi, Y., Matsumiya, W., & Nakamura, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051359 · Cited by 13
“The pathogenesis of LHON seems to involve a combination of decreased complex I driven ATP production, increased reactive oxygen species production, and, ultimately, RGC apoptosis [3].”
BackgroundSong, S., Xu, K., & Zhang, C. (2021) · International Journal of Ophthalmology · doi:10.18240/ijo.2021.11.22 · Cited by 13
Cordeiro, M. F. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1628-z · Cited by 13
Yuan, R., Yang, M., Fan, W., Lan, J., & Zhou, Y. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00510-w · Cited by 12
Modeling Reactive Oxygen Species-Induced Axonal Loss in Leber Hereditary Optic Neuropathy
Lambiri, D. W., & Levin, L. A. (2022) · Biomolecules · doi:10.3390/biom12101411 · Cited by 12
“While neuroretinal effects of the disease are well established [14,15], and studies of postmortem optic nerve samples have been published [16], the actual dynamics of injury propagation in RGCs and the biochemistry of the process that leads to RGC apoptosis are still unknown [7,17].”
BackgroundZou, X.-H., Guo, X.-X., Su, H., Wang, C., Dong, E., Wang, N., Chen, W., & Zhang, Q. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01319-7 · Cited by 12
Stenton, S. L., Laricchia, K. M., Lake, N. J., Chaluvadi, S., Ganesh, V., DiTroia, S. P., Osei‐Owusu, I., Pais, L. S., O’Heir, E., Austin-Tse, C. A., et al. (2025) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2025.100441 · Cited by 11
The human OPA1delTTAG mutation induces adult onset and progressive auditory neuropathy in mice
Affortit, C., Coyat, C., Saidia, A. R., Ceccato, J.-C., Charif, M., Sarzi, E., Flamant, F., Guyot, R., Cazevieille, C., Puel, J., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05115-4 · Cited by 11
“However, the real prevalence of hearing impairments associated with DOA might be higher than reported due to the high variability in disease manifestation and progression [58] as well as the heterogeneity of the clinical profiles of auditory neuropathy [59].”
BackgroundLiu, H., Yuan, J., Tian, Z., Li, X., Song, L., & Li, B. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025307 · Cited by 11
Mutation m.3395A > G in MT-ND1 leads to variable pathologic manifestations
Cortés, N. G., Pertuiset, C., Dumon, E., Börlin, M., Costa, B. D., Guédard, M. L., Stojkovic, T., Loundon, N., Rouillon, I., Nadjar, Y., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa020 · Cited by 11
Morgia, C. L., Carelli, V., & Sadun, A. A. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819975-6.00020-0 · Cited by 11
Self-citationWu, T., He, F. P., Xiao, N., Han, Y., Yang, L. M., & Peng, J. (2022) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2022.04.013 · Cited by 11
Mauri, E., Dilena, R., Boccazzi, A., Ronchi, D., Piga, D., Triulzi, F. M., Gagliardi, D., Brusa, R., Faravelli, I., Bresolin, N., et al. (2018) · BMC Neurology · doi:10.1186/s12883-018-1227-9 · Cited by 10
Ocular Manifestations in Patients with Sensorineural Hearing Loss
Zaheer, H. A., Parameswarappa, D. C., Zaheer, M. A., Chhablani, J. K., & Chhablani, P. P. (2022) · Journal of Ophthalmic and Vision Research · doi:10.18502/jovr.v17i4.12321 · Cited by 10
“[54, 55, 57] Yu-Wai-Man et al[54] found that SNHL was the most common manifestation in patients with ADOAplus syndrome alongside optic atrophy.”
BackgroundInfluential
Metadata
- Authors
- Yu-Wai-Man, P., Votruba, M., Burté, F., La Morgia, C., Barboni, P., & Carelli, V.
- Affiliations
- University Hospital of Wales (GB)
- Wellcome Centre for Mitochondrial Research (GB)
- IRCCS Ospedale San Raffaele (IT)
- Venue
- Acta Neuropathologica
- Published
- 2016-09-30
- Volume
- 132
- Issue
- 6
- Pages
- 789-806
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC5106504
- OpenAlex
- W2526582958
- Cited by
- 176
- References
- 150
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 17 · 2023: 15 · 2022: 27 · 2021: 22 · 2020: 25 · 2019: 12 · 2018: 15 · 2017: 15 · 2016: 2
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Medical Research Council (G1002570)
- National Institute for Health Research
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- mitochondrial optic neuropathy, Leber's hereditary optic neuropathy, autosomal dominant optic atrophy, OPA1, mitochondrial DNA mutations, retinal ganglion cell death, papillomacular bundle, melanopsin, neurodegeneration, mitochondrial dysfunction, disease-modifying therapy, genetic engineering, drug delivery
- MeSH terms
- Animals, DNA, Mitochondrial, Humans, Optic Atrophy, Autosomal Dominant, Optic Atrophy, Hereditary, Leber
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.